An upstart immunotherapy biotech emerges from stealth mode with big love for Kendall Square
When Ron Seidel and Rodolfo “Rudy” Chaparro had to sit down and decide where to base their new biotech, the two investigators at Albert Einstein College of Medicine in New York could have gone just about anywhere in the US that they wanted. Staying in New York would have worked. One had family in California to consider. But a year ago, they chose Cambridge, MA, and started building their team in a place on Kendall Square.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.